Table 1 Demographics

From: Dopaminergic function and intertemporal choice

 

PG (n=12)

Healthy volunteers (n=12)

P

Age

31.3 (8.2)

30.1 (9.3)

0.73

BMI

27.7 (3.5)

27.3 (3.5)

0.82

k

0.0252 (0.002–0.087)

0.0112 (0.000–0.035)

0.06

 Small

0.0651 (0.002–0.159)

0.0256 (0.000–0.065)

0.04

 Medium

0.0252 (0.002–0.158)

0.0097 (0.000–0.064)

0.04

 Large

0.0098 (0.002–0.026)

0.0068 (0.000–0.026)

0.06

 

PD with BA (n=9)

PD without BA (n=8)

P

Age

59.3 (8.4)

60.1 (5.9)

0.83

BMI

25.8 (3.7)

27.8 (2.9)

0.25

MMSE

27.6 (2.0)

28 (1.5)

0.62

Age of PD onset

53.1 (8.7)

55.3 (5.1)

0.56

PD duration

6.1 (1.8)

5.1 (2.0)

0.32

UPDRS-III off

38.7 (7.1)

39.8 (9.8)

0.26

UPDRS-III on

31.7 (4.9)

30.1 (10.7)

0.77

LEDD (mg)

628 (186)

762 (269)

0.25

DA LEDD (mg)

173 (80)

216 (67)

0.27

Levodopa use

n=8

n=7

 

DA use

n=8

n=8

 

k

0.0062 (0.001–0.040)

0.0094 (0.001–0.035)

0.70

 Small

0.0256 (0.002–0.101)

0.0177 (0.002–0.065)

0.56

 Medium

0.0039 (0.001–0.025)

0.0039 (0.002–0.025)

0.80

 Large

0.0039 (0.001–0.026)

0.0098 (0.001–0.026)

0.38

  1. Abbreviations: BA, behavioral addiction; BMI, body mass index; DA, dopamine agonist; k, temporal discounting rate constant; LEDD, levodopa equivalent daily dose; MMSE, Mini-Mental State Examination; PD, Parkinson’s disease; PG, pathological gambling; UPDRS, Unified Parkinson’s Disease Rating Scale.
  2. Mean (s.d.) or median (range) values are presented and group differences were tested using Student’s t-test or Mann–Whitney U-test, as appropriate.
Back to article page